A new study from the Stein Eye Institute resolves the long-standing debate on the structural question of primate cone photoreceptors' disk membranes. Researchers found that the majority of disk membranes are closed, unlike non-mammalian species, with implications for cell biological processes and phototransduction.
Researchers identified three amino acid changes that account for the 30 nm difference in light absorption between red and green cone pigments, enabling precise color discrimination. The study's findings may inform future drug discovery efforts targeting visual photoreceptors.
Researchers discovered a unique photoreceptor cell that optimizes vision in low-light conditions, combining the benefits of both cone and rod cells. This finding has potential applications in developing more efficient cameras and medical treatments for eye conditions such as glaucoma.
A research team led by NTU Singapore has recorded a tiny mechanical twitch in living human and rodent eyes when rod photoreceptors detect light. This breakthrough could provide a new non-invasive way to assess retinal health and diagnose blinding eye diseases earlier.
Researchers from PSI deciphered the structure of an ion channel found in the eye while interacting with calmodulin, a protein that enables cell response to calcium fluctuations. This interaction is believed to be responsible for achieving remarkable sensitivity to dim light.
Biologists developed fluorescent mice to visualize protein kinase A (PKA) activation in the retina. They found that light stimulation activates PKA for nearly 15 minutes in rod cells, which are essential for night vision.
Researchers created a comprehensive single-cell transcriptome atlas of the human retina's aging process. The study reveals regional and cell-type specific differences in gene expression associated with various age-related diseases.
NEI researchers identify 2,054 differentially methylated regions in mouse rod photoreceptors, revealing distinct shifts in gene expression that contribute to age-related disease susceptibility. The study suggests targeting the epigenome as a potential therapeutic strategy to prevent leading causes of vision loss, such as AMD.
Scientists have discovered a way to directly reprogram skin cells into light-sensing rod photoreceptors, enabling blind mice to detect light after transplantation. The technique, which took only 10 days to produce functional cells, has the potential to model eye disease and advance therapies for age-related macular degeneration.
Scientists from Osaka University have discovered a molecular 'light switch' that helps control vision in response to changes in light intensity. The enzyme Cul3-Klhl18 ubiquitin ligase regulates photoreceptor cell adaptation, and its inhibition may help treat conditions like age-related macular degeneration and retinitis pigmentosa.
Researchers developed a gene therapy that eliminates the abnormal copy of rhodopsin and restores it with a healthy copy, preserving retina's light-sensing photoreceptor cells. This approach has the potential to treat a large percentage of patients with rhodopsin autosomal dominant retinitis pigmentosa.
Researchers have reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod photoreceptors. The new technique integrates Müller glia-derived rods into the brain's visual pathway, enabling mice to regain functional vision.
Researchers at Mount Sinai have successfully restored vision in mice by activating retinal stem cells, which could lead to treatments for patients with blinding diseases. The study found that new rod photoreceptor cells were generated and integrated into the existing retinal structure, restoring function of the visual pathway.
A team of researchers has developed a glowing contact lens that reduces the retina's oxygen demands at night, potentially preventing diabetic retinopathy. Early testing shows promising results, with rod cell activity reduced by up to 90 percent when worn in the dark.
A new treatment approach uses a cGMP analogue in a drug delivery system to protect photoreceptors and restore retinal function in rodent models of the disease. The study shows promising results in reducing photoreceptor loss and restoring vision.
Researchers at University of California San Diego use CRISPR/Cas9 to reprogram mutated rod photoreceptors into functioning cone photoreceptors, reversing cellular degeneration and restoring visual function in two mouse models of retinitis pigmentosa. The approach shows promise for advancing human clinical trials.
Researchers found that GARP2 accelerates retinal degeneration in mice, while GARP1 slows its negative effect when both proteins are present. They also developed a standardized nomenclature for OCT measurements in mice, facilitating comparisons with human studies.
A new study led by NIH researchers suggests that rod photoreceptors in mammals evolved from cone cells through a protein-mediated transformation, enabling nocturnal animals to thrive. The findings provide insights into the evolution of night vision and have potential applications for regenerating retinal cells.
In early mammals, rods in the mammalian eye developed from color-detecting cone cells, giving them an edge in low-light conditions. This evolution allowed early mammals to take up a nocturnal lifestyle and survive as predators were dominant during the day.
Researchers at Washington University School of Medicine reprogrammed eye cells to prevent degeneration and allowed mice with retinitis pigmentosa to see. The study aims to develop therapies that can alleviate many forms of visual impairment by modifying existing cells in the eye.
Researchers successfully imaged rod photoreceptors in the living human eye for the first time, revealing cellular structure with unprecedented detail. This breakthrough enables earlier diagnosis and treatment of degenerative eye disorders, potentially leading to more effective sight-saving interventions.
Researchers have found that rod cells in the retina play a crucial role in setting internal biological clocks, even in low light conditions. This discovery has important implications for understanding circadian rhythms and sleep disorders, particularly in older adults who may lose their rod cells to age.
A study by Johns Hopkins University found that blind mice can form low-acuity images using special photosensitive cells in their retinas. This discovery suggests that a blind person could be trained to use these cells to perform simple tasks requiring low visual acuity.
Researchers at Johns Hopkins Medicine have identified a new type of light-sensitive cell in the retina of fish, which challenges current knowledge about retinal function and image vision. This discovery reveals that horizontal cells, previously thought to be only responsive to neighboring nerve cells, can also sense light.
Researchers have discovered that nocturnal mammals' rod cell nuclei are inverted, allowing for reduced light scatter and enhanced low-light vision. This unusual organization enables these animals to perceive light as much as a millionth of daylight's intensity.
Scientists have discovered a key to eye development - a protein called Pias3 that promotes rod cell formation and suppresses cone cell development. This breakthrough could lead to new treatment options for blinding conditions such as macular degeneration.
Researchers at Weill Cornell Medical College have discovered a crucial mechanism driving the growth of light-sensing discs in rod cells, shedding new light on retinal health and disease. The study's findings could lead to significant advances in understanding and treating eye diseases such as retinitis pigmentosa.
Scientists successfully transplanted light-sensing cells into the eyes of mice with retinal degeneration, restoring their visual function. The technique has implications for degenerative eye diseases and suggests that changes in stem cells may be necessary for transplantation to succeed.
Researchers have identified NRL as the earliest marker of rod precursors, allowing them to pinpoint the exact time at which rods are formed. This discovery provides a new vantage point for understanding healthy visual system development and raises the possibility of re-directing cell production to stave off eye disease.
Researchers at the NIH successfully introduced a light-absorbing protein into mouse retinal cells, enabling them to send signals to the brain and regain some visual function. The study suggests that this approach could be used to treat various forms of retinal degenerative eye diseases.
Intrinsically photosensitive retinal ganglion cells (ipRGCs) adapt to lighting conditions, sending signals about overall brightness to the brain. This adaptation allows ipRGCs to regulate pupil size and circadian rhythms.
Researchers found that mice lacking integrin have impaired rod cell uptake, but can still collect debris; a protein trigger is needed to initiate digestion. Synchronizing timing scavenging may be key to maintaining proper cellular function and preventing age-related blindness.
Researchers at EMBL have discovered that the light-sensitive cells in our eyes, rods and cones, originated from an ancient population of light-sensitive cells located in the brain. These brain cells were later recruited for vision, leading to the evolution of the human eye.
Studies using frogs with both rod and cone pigments found identical responses to light, suggesting cellular environments, not pigments, determine functional differences. The findings imply that rods' and cones' sensitivity variations may be due to inherent characteristics of their surroundings rather than pigment properties.
A team of international researchers led by Johns Hopkins scientists has discovered that the eye's ability to detect light is carried out by just three cell types: rods, cones, and melanopsin-producing cells. This finding resolves years of controversy and sheds new light on the eye's non-visual functions.
Researchers found that low-level lead exposure during development in mice injures and kills rod-shaped photoreceptor cells, a crucial component of human vision. The study suggests possible treatments using an anti-death protein called Bcl-xL to prevent cell death in eye disorders.
Researchers have discovered that a specific subset of retinal ganglion cells, containing the protein melanopsin, play a vital role in detecting light and controlling the pupil's response. Without melanopsin, the pupil fails to constrict fully in bright light.
Researchers at Brown University have identified a new photoreceptor cell in the eye that turns light energy into brain signals, governing the body's 24-hour clock and helping people adjust to jet lag. This discovery expands our understanding of visual systems, suggesting a parallel system to the well-known rods and cones.